LAUSR

Translating MSC Therapy in the Age of Obesity

Sign Up to like & get
recommendations!
1 Published in 2022 at "Frontiers in Immunology"

DOI: 10.3389/fimmu.2022.943333

Abstract: Mesenchymal stromal cell (MSC) therapy has seen increased attention as a possible option to treat a number of inflammatory conditions including COVID-19 acute respiratory distress syndrome (ARDS). As rates of obesity and metabolic disease continue… read more here.

Keywords: msc therapy; age obesity; therapy; translating msc ... See more keywords